Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005741 220002244 0 0 Curative (C) 2014-05-27 2014-06-09 AML MyeChild 01 A Mitozantrone/Cytarabine + GO Y N 220028859 NOT MATCHED
220005742 220002244 1.63 90 Curative (C) 2014-09-09 2014-09-13 AML Interim Guidelines FLAG-Ida N N 220028859 FLAG + IDARUBICIN
220005743 220002245 1.67 67 Curative (C) 2015-10-06 2015-10-06 FLAG + Idarubicin N N 220028863 FLAG + IDARUBICIN
220005744 220002245 null null Curative (C) 2017-02-20 2017-02-20 AML MyeChild 01 A Mitozantrone/Cytarabine + GO N N 220028863 NOT MATCHED
220005745 220016021 null 85 Palliative (P) 2014-12-16 2014-12-18 AML Relapsed FLA - Idarubicin N N 220028867 NOT MATCHED
220005746 220002246 null null Curative (C) 2015-02-02 2015-02-02 AML MyeChild 01 A Mitozantrone/Cytarabine N N 220028868 NOT MATCHED
220005747 220002246 null 0 Curative (C) 2014-05-15 2014-05-15 Nilotinib N N 220028868 NILOTINIB
220005748 220002246 0 0 Curative (C) 2017-12-04 2017-12-04 Nilotinib N N 220028868 NILOTINIB
220005749 220002247 1.77 106.6 Curative (C) 2016-02-13 2016-02-13 FLAG + Idarubicin N N 220028877 FLAG + IDARUBICIN
220005750 220002247 null 68.8 Curative (C) 2016-08-15 2016-08-23 AML 19 TRIAL 1 N 220028877 AML19 TRIAL
220005751 220002247 1.65 93.5 Curative (C) 2015-03-18 2015-03-18 AML 19 TRIAL Y N 220028877 AML19 TRIAL
220005752 220002247 0 0 Palliative (P) 2014-02-17 2014-05-21 Nilotinib N N 220028877 NILOTINIB
220005753 220002248 null null Curative (C) 2017-10-12 2017-11-02 Nilotinib 02 N 220028886 NILOTINIB
220005754 220002248 1.74 0 Palliative (P) 2013-03-21 2013-03-21 Nilotinib N N 220028886 NILOTINIB
220005755 220002249 1.68 null Curative (C) 2017-01-14 2017-01-14 AML 19 TRIAL 2 N 220028890 AML19 TRIAL
220005756 220002249 1.73 106 Curative (C) 2016-12-22 2016-12-22 FLAG + Idarubicin N N 220028890 FLAG + IDARUBICIN
220005757 220002249 1.6 null Curative (C) 2015-04-18 2015-07-11 FLAG + Idarubicin N N 220028890 FLAG + IDARUBICIN
220005758 220002249 0.81 48 Curative (C) 2015-11-08 2015-11-08 CYTARABINE + Hydroxycarbamide 2 N 220028890 NOT MATCHED
220005763 220020335 1.87 69.4 Curative (C) null 2016-02-20 AML 19 TRIAL Y N 220028901 AML19 TRIAL
220005764 220020335 1.71 88 Curative (C) null 2015-05-05 AML 19 TRIAL Y N 220028901 AML19 TRIAL
220005765 220020335 1.75 76.4 Curative (C) 2013-10-02 2013-10-04 AML 19 TRIAL 01 N 220028901 AML19 TRIAL
220005766 220002251 1.73 81.6 Curative (C) 2014-05-01 2014-05-01 AML 19 TRIAL 01 N 220028910 AML19 TRIAL
220005767 220002251 null 0 Curative (C) 2015-06-09 2015-06-09 Nilotinib N N 220028910 NILOTINIB
220005768 220002251 0 null Curative (C) 2013-07-12 2013-07-12 null Y N 220028910 NOT MATCHED
220005769 220002251 1.47 101.8 Curative (C) null 2016-03-28 FLAG + Idarubicin N N 220028910 FLAG + IDARUBICIN
220005770 220002252 1.58 61.6 Curative (C) 2015-03-18 2015-03-18 AML 19 TRIAL 1 N 220028923 AML19 TRIAL
220005771 220002252 1.73 95.2 Curative (C) null 2016-04-06 FLAG + Idarubicin Y N 220028923 FLAG + IDARUBICIN
220005772 220002252 null 0 Curative (C) 2013-07-19 2013-07-26 AML Interim Guidelines FLA Y N 220028923 NOT MATCHED
220005773 220002252 1.75 null Curative (C) 2014-08-20 2014-08-20 null N N 220028923 NOT MATCHED
220005774 220002253 1.74 104 Curative (C) 2017-05-21 2017-05-21 AML Downs AIE 02 N 220028933 NOT MATCHED
220005775 220002253 1.73 78.9 Curative (C) 2014-03-14 2014-05-08 AML 19 TRIAL 01 N 220028933 AML19 TRIAL
220005776 220002253 null 52.4 Curative (C) 2017-04-18 2017-04-21 AML 19 TRIAL Y N 220028933 AML19 TRIAL
220005777 220002253 1.85 86.1 Curative (C) null 2014-08-19 AML 19 TRIAL Y N 220028933 AML19 TRIAL
220005778 220002253 0 83.5 Palliative (P) 2017-05-03 2017-05-03 Nilotinib 2 Y 220028933 NILOTINIB
220005779 220002254 0 12.8 Curative (C) 2013-07-03 2013-07-03 AML MyeChild 01 A Mitozantrone/Cytarabine Y N 220028943 NOT MATCHED
220005780 220002254 null 74 Palliative (P) 2017-06-21 2017-06-21 APML Consolidation III ATRA, Idarubicin, Cytarabine N N 220028943 NOT MATCHED
220005781 220002255 null 12.2 Curative (C) 2019-03-18 2019-03-19 AML Interim Guidelines FLA -Ida Y N 220028946 NOT MATCHED
220005782 220002256 0 null Disease modification (D) 2013-08-04 2013-08-04 Nilotinib 02 N 220028948 NILOTINIB
220005783 220002256 1.7 0 Not known (9) 2016-02-20 2016-02-20 Nilotinib N N 220028948 NILOTINIB
220005784 220002256 1.85 75.4 Curative (C) 2015-12-20 2015-12-24 AML 19 TRIAL Y N 220028948 AML19 TRIAL
220005785 220002256 1.55 72 Curative (C) 2014-11-03 2014-11-03 AML 19 TRIAL 1 N 220028948 AML19 TRIAL
220005790 220020337 1.79 0 Palliative (P) 2016-04-08 2016-04-09 Nilotinib 02 N 220028960 NILOTINIB
220005791 220020337 1.85 118.9 Curative (C) null 2014-05-27 AML 19 TRIAL N N 220028960 AML19 TRIAL
220005792 220021719 1.54 56 Curative (C) 2016-05-26 2016-05-26 AML 19 TRIAL Y N 220028965 AML19 TRIAL
220005793 220002258 1.74 98 Palliative (P) 2014-12-31 2014-12-31 Nilotinib 02 N 220028966 NILOTINIB
220005794 220002258 1.84 null Curative (C) null 2016-01-21 FLAG + Idarubicin N N 220028966 FLAG + IDARUBICIN
220005795 220002258 1.72 68.6 Curative (C) 2016-04-16 2016-04-16 AML 19 TRIAL N N 220028966 AML19 TRIAL
220005796 220002258 1.72 67.6 Curative (C) 2016-03-06 2016-03-07 AML 19 TRIAL 01 N 220028966 AML19 TRIAL
220005797 220002259 1.64 74.5 Curative (C) 2017-10-03 2017-10-03 AML 19 TRIAL N N 220028973 AML19 TRIAL
220005798 220002259 1.71 81.8 Curative (C) 2014-10-24 2014-10-24 AML 19 TRIAL 01 null 220028973 AML19 TRIAL